NETSPOT (Gallium-68 dotatate)

NETSPOT (Gallium-68) dotatate

For diagnosis of Neuroendocrine Tumors

What is NETSPOT (Gallium-68)?

NETSPOT is the first Gallium-68 injection, a radioactive diagnostic agent for PET/CT imaging. This scan helps accurately locate and characterize tumors in adult patients with somatostatin-receptor positive Neuroendocrine Tumors (NETs).

Gallium-68 dotatate (NETSPOT) is a new FDA-approved radiopharmaceutical test that makes Neuroendocrine Tumors visible on medical images for the purpose of accurate diagnosis and tracking.

What are Neuroendocrine Tumors?

Neuroendocrine Tumors (NETs) are a group of uncommon tumors. There are several types of NETs, but most occur throughout the gastrointestinal tract and lungs. They have become the second most common cancer of the gastrointestinal tract.

Symptoms often resemble those of other diseases, like sweating, diarrhea, abdominal pain, and GI bleeding. This can lead to delays in diagnosis or even misdiagnosis and inappropriate treatment. However, advances in treatment have made it possible for more and more patients to be accurately diagnosed, seek the most appropriate treatment, and live with the disease.


What can I expect?

The Axumin PET/CT Scan introduces an innovative, FDA-approved tracer called fluorine 18 to create clear images of your internal organs and tissue. Once the tracer is injected, you will lie on the scanner table with your arms over your head. During the scan, you will need to lie still as the bed slowly moves through the PET/CT machine, which is shaped like a large donut. The scan only takes about 30 minutes.

How can I prepare?

In order to prepare for your Axumin injection and scan, you will need to avoid high-intensity exercise 24-hours prior to your procedure. You will also need to avoid food and beverages for at least 4 hours prior to your PET/CT scan (other than a few ounces of water as needed for taking medications).

Available in Fredericksburg

We offer comprehensive services for your oncology imaging needs. Our physicians are Board Certified in Diagnostic Radiology and Fellowship Trained in Nuclear Medicine.

Local Access to Cutting-Edge Tech

“Providing our patients with local access to this cutting-edge molecular imaging technology means they no longer need to travel to NOVA or D.C. for their advanced PET-CT scans.”

-Chris Snyder, Practice Administrator

Medical Imaging of Fredericksburg Reopens. Great service and best regional pricing.

As we are turning the corner in the Fredericksburg region from COVID-19, Medical Imaging of Fredericksburg is pleased to resume scheduled appointments at all six of our locations. On May 4th, Medical Imaging of Fredericksburg will reopen all of its facilities for scheduled appointments. In accordance with official guidance, we have modified our patient services to protect the health of the public and our staff,

Radiologic Associates of Fredericksburg Ranks with “Exemplary 80” in Group Practice Radiology

Radiologic Associates of Fredericksburg (RAF) is pleased to announce its ranking among the Exemplary 80 in the 2019 group practice survey conducted by Radiology Business Journal (RBJ). This is the 12th annual recognition for Radiologic Associates of Fredericksburg by Radiology Business Journal.

RBJ’s survey, previously known as the Radiology 100 survey, was changed to the Exemplary 80 in 2019’s survey,

Breast cancer: understanding the risks, symptoms, and ultimate prevention.

You’re more likely to be diagnosed with breast cancer than any other cancer (besides skin cancer). Breast cancer is the second leading cause of cancer deaths in women in the U.S. 

But it doesn’t have to be this way. 

Thanks to earlier detection and increased awareness, breast cancer mortality rates have been significantly reduced.

Our Accreditation